Early Detection of Proprioceptive Dysfunction in Degenerative Cervical Myelopathy by Proprioceptive Functional Analysis in Activities of Daily Living

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Proprioceptive deficits in degenerative cervical myelopathy (DCM) is a progressive neurological deficits in somatosensory and motor function which affects the body balance and motor control. DCM usually presents with body incoordination, hand clumsiness and gait disturbance associated with proprioceptive dysfunction that hinders the physical performance and functions. In this study, a non-invasive assessment protocol on proprioception will be developed for detecting subtle proprioceptive deficits at the early stage of disease through simple Physical Performance Tests for population older than 45. By adopting the physical performance tests as the diagnostic predictors of DCM, we aim to avoid the development of devastating consequences and disabilities.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: t
View:

• Chinese

• Aged 50 or above

• With radiological evidence of degenerative cervical myelopathy, both symptomatic and asymptomatic

• Nurick grade less than 3

Locations
Other Locations
Hong Kong Special Administrative Region
The Duchess of Kent Children's Hospital at Sandy Bay
RECRUITING
Hong Kong
Contact Information
Primary
Karlen Ka Pui Law, M. Phil
karlenhk@connect.com.hk
852-29740531
Time Frame
Start Date: 2022-09-01
Estimated Completion Date: 2036-09-30
Participants
Target number of participants: 100
Treatments
(1) Degenerative Cervical Myelopathy
Chinese subjects aged 50 or above who have radiological evidence of Degenerative Cervical Myelopathy, symptomatic with Nurick Grade less than 3 will be included.
(2) Healthy Controls
Chinese healthy controls aged 50 or above who have no myelopathic signs of Degenerative Cervical Myelopathy with Nurick Grade less than 3 will be included.
Sponsors
Leads: The University of Hong Kong

This content was sourced from clinicaltrials.gov